Beauty Health (SKIN) to Announce Earnings on Thursday

Beauty Health (NASDAQ:SKIN) is projected to release its Q2 2026 results after the market closes on Thursday, August 6th. Analysts expect the company to post earnings of ($0.04) per share and revenue of $74.45 million for the quarter. Interested persons may visit the the company’s upcoming Q2 2026 earning overview page for the latest details on the call scheduled for Thursday, August 6, 2026 at 4:30 PM ET.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings data on Thursday, May 7th. The company reported ($0.05) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.09) by $0.04. The business had revenue of $64.91 million during the quarter, compared to the consensus estimate of $66.28 million. Beauty Health had a negative net margin of 2.03% and a negative return on equity of 9.38%. On average, analysts expect Beauty Health to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Beauty Health Stock Up 2.0%

Shares of Beauty Health stock opened at $0.70 on Tuesday. The stock has a market capitalization of $90.59 million, a price-to-earnings ratio of -4.11 and a beta of 1.07. The business’s 50 day simple moving average is $0.74 and its 200-day simple moving average is $0.93. The company has a current ratio of 1.79, a quick ratio of 1.48 and a debt-to-equity ratio of 4.37. Beauty Health has a twelve month low of $0.55 and a twelve month high of $2.69.

Hedge Funds Weigh In On Beauty Health

A number of institutional investors and hedge funds have recently bought and sold shares of SKIN. Invesco Ltd. raised its position in shares of Beauty Health by 65.4% during the 4th quarter. Invesco Ltd. now owns 69,422 shares of the company’s stock worth $96,000 after buying an additional 27,453 shares in the last quarter. Millennium Management LLC boosted its holdings in shares of Beauty Health by 127.0% in the fourth quarter. Millennium Management LLC now owns 5,764,802 shares of the company’s stock valued at $8,013,000 after acquiring an additional 3,225,668 shares in the last quarter. AQR Capital Management LLC increased its stake in shares of Beauty Health by 270.1% during the fourth quarter. AQR Capital Management LLC now owns 333,196 shares of the company’s stock valued at $463,000 after acquiring an additional 243,179 shares during the period. Atom Investors LP bought a new stake in Beauty Health during the fourth quarter worth approximately $29,000. Finally, Squarepoint Ops LLC lifted its position in Beauty Health by 22.6% in the fourth quarter. Squarepoint Ops LLC now owns 275,885 shares of the company’s stock worth $383,000 after purchasing an additional 50,794 shares during the period. Institutional investors own 93.26% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on SKIN shares. Roth Capital reissued a “buy” rating and set a $2.00 price target (down from $2.50) on shares of Beauty Health in a report on Wednesday, May 20th. Weiss Ratings downgraded shares of Beauty Health from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, July 23rd. Canaccord Genuity Group reduced their target price on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Friday, May 1st. Finally, Zacks Research cut shares of Beauty Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 20th. One analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $1.52.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.